Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saccharomyces boulardii in diarrhea-predominant IBS
NCT00589771Phase 3Completed
- Sponsor
- Aga Khan University
- Start
- Jan 2010
- Primary completion
- Dec 2011
- Modality
- Microbiome Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of saccharomyces boulardii in Irritable bowel syndrome with diarrhea (IBS-D), sponsored by Aga Khan University. Started Jan 2010; status: completed.
02
Drugs
saccharomyces boulardii
03
Conditions
Irritable bowel syndrome with diarrhea (IBS-D)
Beyond the preview
Go deeper on NCT00589771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00589771.